149 related articles for article (PubMed ID: 37944928)
1. Prognostic Impact of AGR3 Protein Expression in Breast Cancer: A Systematic Review and Meta-analysis.
Moraes CL; Mendonça CR; Melo NCE; Tacon FSA; Junior JPM; Amaral WND
Rev Bras Ginecol Obstet; 2023 Oct; 45(10):e609-e619. PubMed ID: 37944928
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient 3 Promotes Breast Cancer Development and Chemotherapy Response.
Xu Q; Shao Y; Zhang J; Zhang H; Zhao Y; Liu X; Guo Z; Chong W; Gu F; Ma Y
Cancer Res Treat; 2020 Jan; 52(1):218-245. PubMed ID: 31291711
[TBL] [Abstract][Full Text] [Related]
3. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
4. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
5. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
Obacz J; Brychtova V; Podhorec J; Fabian P; Dobes P; Vojtesek B; Hrstka R
Onco Targets Ther; 2015; 8():1523-32. PubMed ID: 26170690
[TBL] [Abstract][Full Text] [Related]
6. Profile of anterior gradient 3 (AGR3) mRNA expression and serum levels in benign and malignant breast tumors.
Prihantono P; Rahardjo W; Syamsu SA; Smaradhania N
Breast Dis; 2021; 40(S1):S39-S43. PubMed ID: 34057117
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
Zhang Z; Fang T; Lv Y
World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
[TBL] [Abstract][Full Text] [Related]
9. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer.
Jiang R; Sun Y; Chen X; Shi P
Breast Cancer Res Treat; 2021 Nov; 190(2):203-211. PubMed ID: 34519905
[TBL] [Abstract][Full Text] [Related]
13. Survival and clinicopathological significance of blood vessel invasion in operable breast cancer: a systematic review and meta-analysis.
Lin Y; Zhang Y; Fang H; Hu Q; Duan H; Zhang L; Pang D
Jpn J Clin Oncol; 2023 Jan; 53(1):35-45. PubMed ID: 36156086
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
15. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Pan F; Mao H; Deng L; Li G; Geng P
Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
Lee WS; Park SY; Park YL; Joo YE
In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
